Antibiotic comparison for children with resistant mycoplasma pneumonia
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This study compares two antibiotics to find which works better in children with pneumonia caused by a bacteria called mycoplasma that may not respond to usual treatments. It helps choose the most effective treatment for this specific infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 3 and 17 years old.
- Your child must have pneumonia confirmed by a chest X-ray and symptoms like fever or cough.
- The pneumonia must be caused by mycoplasma bacteria, or strongly suspected based on symptoms or an outbreak at school.
- The bacteria is likely resistant to standard antibiotics (like azithromycin).
- The study drug must be started within 72 hours of the first symptoms.
- Your child must not have taken certain antibiotics (tetracyclines, macrolides, or quinolones) for this illness already.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether azithromycin (a macrolide antibiotic) is better than a placebo for treating mycoplasma pneumonia in children aged 3–17. If your child has pneumonia caused by mycoplasma, this study may help find the best treatment.
This trial compares two antibiotics, azithromycin and doxycycline, when given alongside a standard beta-lactam antibiotic to hospitalized adults with community-acquired pneumonia. It aims to see which combination works better and is safer.
This trial compares different antibiotic strategies for children with pneumonia who are being treated as outpatients. The goal is to find the best approach to treat the infection and help your child recover.
This trial tests whether twice-daily amoxicillin helps treat non-severe pneumonia in children. It may be a good option if your child has a mild form confirmed by symptoms and a chest X-ray.
This trial tests whether the antibiotic azithromycin can help children in the hospital who are having asthma-like breathing symptoms. If you qualify, your child may get azithromycin as part of the study and will be monitored closely for side effects and breathing improvement.
This study tests whether giving amoxicillin for 3 days works as well as the usual 5 days for children with pneumonia. It aims to reduce antibiotic use while still curing the infection.
Hear when a new Mycoplasma Pneumoniae trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.